86 is the total number of securities Nan Fung Group Holdings Ltd has owned. The longest Nan Fung Group Holdings Ltd has owned a single stock is 10 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
KRTX | KARUNA THERAPEUTICS INC | 10 | 10 | 8.32% | 21.57% | 34.69% | Q2 2021 | Q3 2023 | 10 |
HRMY | HARMONY BIOSCIENCES HL... | 10 | 10 | 6.74% | 11.96% | 21.30% | Q2 2021 | Q3 2023 | 10 |
XENE | XENON PHARMACEUTICALS INC | 10 | 10 | 0.97% | 2.35% | 3.11% | Q2 2021 | Q3 2023 | 10 |
BOLT | BOLT BIOTHERAPEUTICS INC | 10 | 10 | 0.96% | 2.04% | 5.60% | Q2 2021 | Q3 2023 | 10 |
GRTX | GALERA THERAPEUTICS INC | 10 | 10 | 0.09% | 0.92% | 1.87% | Q2 2021 | Q3 2023 | 10 |
KALV | KALVISTA PHARMACEUTICA... | 10 | 10 | 0.31% | 0.69% | 1.83% | Q2 2021 | Q3 2023 | 10 |
EXEL | EXELIXIS INC | 10 | 10 | 0.35% | 0.69% | 1.14% | Q2 2021 | Q3 2023 | 10 |
DBVT | DBV TECHNOLOGIES S A | 10 | 10 | 0.18% | 0.43% | 0.65% | Q2 2021 | Q3 2023 | 10 |
ALXO | ALX ONCOLOGY HLDGS INC | 10 | 10 | 0.13% | 0.35% | 0.99% | Q2 2021 | Q3 2023 | 10 |
ILMN | ILLUMINA INC | 9 | 9 | 13.25% | 16.17% | 21.48% | Q3 2021 | Q3 2023 | 9 |
SOMALOGIC INC | 9 | 9 | 2.50% | 4.34% | 6.73% | Q3 2021 | Q3 2023 | 9 | |
RANI THERAPEUTICS HLDG... | 9 | 9 | 0.87% | 2.31% | 3.50% | Q3 2021 | Q3 2023 | 9 | |
SGEN | SEAGEN INC | 8 | 8 | 2.07% | 4.96% | 8.09% | Q4 2021 | Q3 2023 | 8 |
EXSCIENTIA PLC | 8 | 8 | 3.10% | 4.08% | 5.76% | Q4 2021 | Q3 2023 | 8 | |
INCY | INCYTE CORP | 8 | 8 | 0.75% | 1.46% | 1.90% | Q4 2021 | Q3 2023 | 8 |
BGNE | BEIGENE LTD | 8 | 8 | 0.90% | 1.38% | 1.82% | Q4 2021 | Q3 2023 | 8 |
PACB | PACIFIC BIOSCIENCES CA... | 8 | 8 | 0.44% | 0.82% | 1.16% | Q4 2021 | Q3 2023 | 8 |
NVTA | INVITAE CORP | 8 | 8 | 0.01% | 0.52% | 1.52% | Q2 2021 | Q1 2023 | 8 |
ACAD | ACADIA PHARMACEUTICALS... | 8 | 8 | 0.24% | 0.36% | 0.51% | Q4 2021 | Q3 2023 | 8 |
BMRN | BIOMARIN PHARMACEUTICA... | 8 | 8 | 0.20% | 0.31% | 0.48% | Q4 2021 | Q3 2023 | 8 |
ARGX | ARGENX SE | 8 | 8 | 0.12% | 0.30% | 0.57% | Q4 2021 | Q3 2023 | 8 |
KOD | KODIAK SCIENCES INC | 8 | 8 | 0.03% | 0.11% | 0.34% | Q4 2021 | Q3 2023 | 8 |
ABCL | ABCELLERA BIOLOGICS INC | 8 | 8 | 0.05% | 0.07% | 0.09% | Q4 2021 | Q3 2023 | 8 |
EAR | EARGO INC | 7 | 7 | 1.17% | 8.32% | 35.80% | Q2 2021 | Q4 2022 | 7 |
REPL | REPLIMUNE GROUP INC | 7 | 7 | 0.60% | 2.19% | 3.55% | Q1 2022 | Q3 2023 | 7 |
ENTRADA THERAPEUTICS INC | 7 | 7 | 0.48% | 0.88% | 1.45% | Q1 2022 | Q3 2023 | 7 | |
STSA | SATSUMA PHARMACEUTICAL... | 7 | 7 | 0.08% | 0.28% | 0.68% | Q3 2021 | Q1 2023 | 7 |
RETA | REATA PHARMACEUTICALS INC | 6 | 1 | 0.06% | 0.19% | 0.36% | Q2 2021 | Q2 2023 | 7 |
FGEN | FIBROGEN INC | 7 | 7 | 0.04% | 0.18% | 0.43% | Q1 2022 | Q3 2023 | 7 |
AFMD | AFFIMED N V | 7 | 7 | 0.11% | 0.17% | 0.32% | Q1 2022 | Q3 2023 | 7 |
SYBX | SYNLOGIC INC | 7 | 7 | 0.04% | 0.06% | 0.08% | Q2 2021 | Q4 2022 | 7 |
CERS | CERUS CORP | 7 | 7 | 0.02% | 0.03% | 0.05% | Q1 2022 | Q3 2023 | 7 |
OTIC | OTONOMY INC | 6 | 6 | 0.16% | 0.66% | 1.22% | Q2 2021 | Q3 2022 | 6 |
ASND | ASCENDIS PHARMA A/S | 6 | 6 | 0.23% | 0.32% | 0.50% | Q4 2021 | Q1 2023 | 6 |
ISEE | IVERIC BIO INC | 5 | 5 | 1.28% | 1.83% | 2.82% | Q2 2022 | Q2 2023 | 5 |
VIR | VIR BIOTECHNOLOGY INC | 4 | 4 | 1.01% | 2.10% | 2.61% | Q2 2021 | Q1 2022 | 4 |
KDNY | CHINOOK THERAPEUTICS INC | 4 | 4 | 1.43% | 2.02% | 2.80% | Q3 2022 | Q2 2023 | 4 |
MRUS | MERUS N V | 4 | 4 | 1.00% | 2.01% | 2.62% | Q4 2022 | Q3 2023 | 4 |
BEAM | BEAM THERAPEUTICS INC | 4 | 4 | 1.29% | 1.57% | 1.95% | Q2 2021 | Q1 2022 | 4 |
AVTE | AEROVATE THERAPEUTICS INC | 4 | 4 | 0.52% | 0.68% | 1.02% | Q4 2022 | Q3 2023 | 4 |
BMEA | BIOMEA FUSION INC | 4 | 4 | 0.35% | 0.66% | 1.27% | Q4 2022 | Q3 2023 | 4 |
SRRA | SIERRA ONCOLOGY INC | 4 | 4 | 0.34% | 0.58% | 0.80% | Q2 2021 | Q1 2022 | 4 |
RYTM | RHYTHM PHARMACEUTICALS... | 4 | 4 | 0.40% | 0.55% | 0.74% | Q4 2022 | Q3 2023 | 4 |
EXAS | EXACT SCIENCES CORP | 4 | 4 | 0.40% | 0.55% | 0.68% | Q2 2021 | Q1 2022 | 4 |
RUBY | RUBIUS THERAPEUTICS INC | 4 | 4 | 0.15% | 0.27% | 0.43% | Q2 2021 | Q1 2022 | 4 |
AKRO | AKERO THERAPEUTICS INC | 2 | 2 | 0.02% | 0.09% | 0.18% | Q2 2021 | Q3 2023 | 4 |
BCRX | BIOCRYST PHARMACEUTICA... | 3 | 1 | 0.06% | 0.09% | 0.10% | Q4 2021 | Q3 2023 | 4 |
NFH | NEW FRONTIER HEALTH CORP | 3 | 3 | 28.31% | 29.10% | 30.02% | Q2 2021 | Q4 2021 | 3 |
OCULIS HOLDING AG | 3 | 3 | 3.29% | 4.61% | 5.40% | Q1 2023 | Q3 2023 | 3 | |
NFHWS | NEW FRONTIER HEALTH CORP | 3 | 3 | 1.14% | 1.28% | 1.43% | Q2 2021 | Q4 2021 | 3 |
CCXI | CHEMOCENTRYX INC | 3 | 3 | 0.43% | 0.74% | 1.18% | Q1 2022 | Q3 2022 | 3 |
GITLAB INC | 3 | 3 | 0.22% | 0.43% | 0.86% | Q4 2022 | Q2 2023 | 3 | |
TVTX | TRAVERE THERAPEUTICS INC | 2 | 1 | 0.37% | 0.40% | 0.44% | Q4 2021 | Q1 2023 | 3 |
EARGO INC | 3 | 3 | 0.26% | 0.40% | 0.47% | Q1 2023 | Q3 2023 | 3 | |
2SEVENTY BIO INC | 3 | 3 | 0.33% | 0.36% | 0.37% | Q1 2022 | Q3 2022 | 3 | |
MDGL | MADRIGAL PHARMACEUTICA... | 3 | 3 | 0.18% | 0.20% | 0.24% | Q4 2022 | Q2 2023 | 3 |
DYN | DYNE THERAPEUTICS INC | 3 | 3 | 0.04% | 0.05% | 0.06% | Q3 2021 | Q1 2022 | 3 |
GERN | GERON CORP | 2 | 2 | 0.80% | 1.04% | 1.29% | Q2 2023 | Q3 2023 | 2 |
CABA | CABALETTA BIO INC | 2 | 2 | 0.34% | 0.46% | 0.58% | Q2 2023 | Q3 2023 | 2 |
SRPT | SAREPTA THERAPEUTICS INC | 2 | 2 | 0.14% | 0.17% | 0.20% | Q1 2022 | Q2 2022 | 2 |
FLNT | FLUENT INC | 2 | 2 | 0.14% | 0.16% | 0.18% | Q2 2021 | Q3 2021 | 2 |
ATHA | ATHIRA PHARMA INC | 2 | 2 | 0.02% | 0.16% | 0.29% | Q2 2023 | Q3 2023 | 2 |
NRIX | NURIX THERAPEUTICS INC | 2 | 2 | 0.07% | 0.08% | 0.09% | Q4 2022 | Q1 2023 | 2 |
DAWN | DAY ONE BIOPHARMACEUTI... | 2 | 2 | 0.05% | 0.06% | 0.06% | Q4 2021 | Q1 2022 | 2 |
TCRR | TCR2 THERAPEUTICS INC | 2 | 2 | 0.02% | 0.03% | 0.04% | Q1 2022 | Q2 2022 | 2 |
SNOW | SNOWFLAKE INC | 1 | 1 | 1.84% | 1.84% | 1.84% | Q2 2022 | Q2 2022 | 1 |
ALPN | ALPINE IMMUNE SCIENCES... | 1 | 1 | 1.69% | 1.69% | 1.69% | Q3 2023 | Q3 2023 | 1 |
MELI | MERCADOLIBRE INC | 1 | 1 | 0.81% | 0.81% | 0.81% | Q1 2023 | Q1 2023 | 1 |
ARDX | ARDELYX INC | 1 | 1 | 0.77% | 0.77% | 0.77% | Q2 2021 | Q2 2021 | 1 |
HASHICORP INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q2 2022 | Q2 2022 | 1 | |
BLUE | BLUEBIRD BIO INC | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2021 | Q4 2021 | 1 |
DICE THERAPEUTICS INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2021 | Q4 2021 | 1 | |
RLMD | RELMADA THERAPEUTICS INC | 1 | 1 | 0.13% | 0.13% | 0.13% | Q3 2022 | Q3 2022 | 1 |
LEGN | LEGEND BIOTECH CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2021 | Q4 2021 | 1 |
SURROZEN INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2021 | Q4 2021 | 1 | |
KYMR | KYMERA THERAPEUTICS INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2021 | Q4 2021 | 1 |
TANGO THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2021 | Q4 2021 | 1 | |
MRTX | MIRATI THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2021 | Q4 2021 | 1 |
PRLD | PRELUDE THERAPEUTICS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2021 | Q4 2021 | 1 |
CNTA | CENTESSA PHARMACEUTICA... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2021 | Q4 2021 | 1 |
TSCAN THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2021 | Q4 2021 | 1 | |
AMYT | AMRYT PHARMA PLC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2021 | Q4 2021 | 1 |
LIFE | ATYR PHARMA INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2021 | Q4 2021 | 1 |
KURA | KURA ONCOLOGY INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q4 2021 | Q4 2021 | 1 |
VINC | VINCERX PHARMA INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
AMRN | AMARIN CORP PLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q4 2021 | Q4 2021 | 1 |
Download |
The securities at the top of the list , including KARUNA THERAPEUTICS INC, HARMONY BIOSCIENCES HLDGS IN, and XENON PHARMACEUTICALS INC, are the highest-conviction holdings of Nan Fung Group Holdings Ltd.
The conviction is calculated by counting the number of quarters a security has been reported by Nan Fung Group Holdings Ltd. The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that Nan Fung Group Holdings Ltd owns currently or has owned in the past.